Additionally, alpha2M has been shown to have synergistic effects when combined with other antihypertensive agents, suggesting its potential as an adjunctive therapy in the management of hypertension (Raymond et al., 2009; Lagrange et al., 2022). The gene discussed is A2M; the disease is hypertensive disorder.